Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Somewhat Bullish +50

Wall Street Analysts See a 25.06% Upside in Intuitive Surgical (ISRG): Can the Stock Really Move This High? - Eastern Progress

📈 Intuitive Surgical (ISRG) shares closed at $470.99 after gaining 4% over the past four weeks.

🎯 Wall Street analysts calculate a mean short-term price target of $589, implying 25.1% upside potential from current levels.

📊 Analyst estimates range from a low of $440 (6.6% downside) to a high of $750 (59.2% upside).

⚖️ The standard deviation for analyst price targets is $63.45, indicating variability in the short-term consensus.

🛑 Research suggests that price targets often mislead investors due to business incentives between firms and analysts.

📉 Overly optimistic price targets may be set to promote coverage rather than reflect accurate valuations.

🤝 A tight clustering of price targets, like ISRG's standard deviation, signals strong analyst agreement despite potential bias.

📈 EPS estimate revisions have been predominantly positive, with 11 rising and only 1 falling in the last 30 days.

🆙 The Zacks Consensus Estimate for earnings has increased by 4.3% over the same period.

🏆 ISRG currently holds a Zacks Rank #2 (Buy), placing it in the top 20% of nearly 4,000 ranked stocks based on earnings factors.

🔄 Historical data shows a strong correlation between positive earnings estimate revision trends and near-term stock price gains.

⚠️ Investors are cautioned not to rely solely on price targets but should view them as a guide rather than a guarantee.

🔭 The article concludes that while the magnitude of the gain is uncertain, the upward directional bias of targets is valid.

Bullish Signals
  • Shares of Intuitive Surgical (ISRG) gained 4% over the past four weeks, closing at $470.99.
  • Wall Street analysts indicate a mean short-term price target of $589, suggesting a potential upside of 25.1% from current levels.
  • The most optimistic analyst forecasts a 59.2% surge in the stock price to reach $750.00.
  • A tight clustering of price targets demonstrates strong agreement among analysts regarding the company's upward potential.
  • There has been increasing optimism among analysts about ISRG's earnings prospects, with the Zacks Consensus Estimate increasing 4.3%.
  • Eleven estimates have moved higher over the last 30 days while only one has gone lower.
  • ISRG holds a Zacks Rank #2 (Buy), placing it in the top 20% of more than 4,000 stocks based on earnings estimate factors.
  • The company boasts an impressive externally-audited track record which supports conclusions about its near-term upside potential.
Risk Factors
  • Analyst consensus price targets have been historically unreliable, as empirical research indicates they mislead investors more often than they guide actual stock direction.
  • Many analysts set overly optimistic price targets to drum up interest in companies with which their own firms have business relationships or seek associations, potentially inflating the mean estimate of $589 for ISRG.
  • Despite a Zacks Rank #2 (Buy) status, the article notes that even high-probability picks have failure rates ('all our elite picks aren't winners'), and references past doubles like Hims & Hers Health as potential anomalies rather than guaranteed benchmarks.
  • The standard deviation among analyst estimates is $63.45, indicating significant variability in predictions, with the lowest estimate projecting a 6.6% decline from current levels, suggesting downside risk if sentiment shifts.
Full Analysis
Shares of Intuitive Surgical (ISRG) have gained 4% over the past four weeks to close the last trading session at $470.99, presenting analysts with a mean price target estimate of $589 that suggests a potential upside of approximately 25.1%. The consensus figure is derived from 26 short-term price targets with a standard deviation of $63.45, ranging from a low estimate of $440.00 indicating a 6.6% decline to a high target of $750.00 representing a 59.2% surge. While investors often seek the consensus price target, the article notes that empirical research suggests these targets can frequently mislead due to business incentives leading analysts to inflate their projections for companies they cover or wish to associate with. Despite the limitations of relying solely on price targets, there is significant optimism surrounding Intuitive Surgical's earnings prospects supported by strong agreement among analysts regarding upward EPS estimate revisions. Over the last 30 days, 11 estimates have moved higher compared to only one that went lower, resulting in a 4.3% increase in the Zacks Consensus Estimate. This positive trend is particularly notable as research indicates a strong correlation between trends in earnings estimate revisions and near-term stock price movements. The company currently holds a Zacks Rank #2 (Buy), placing it in the top 20% among more than 4,000 stocks based on four specific factors related to earnings estimates, which serves as an additional indicator of its potential upside. The article concludes that while investors should treat price targets with skepticism and avoid making decisions based entirely on them due to potential biases, the direction implied by a tight clustering of estimates provides a valid guide for further fundamental research. The upward trajectory of earnings estimates is viewed as a more reliable metric than the absolute price targets themselves. This perspective comes alongside broader market commentary that highlights ISRG's recent performance and its position within the top-ranked stocks, though the text also includes promotional content regarding a separate list of satellite communications firm picks unrelated to Intuitive Surgical.